
aug pm et
summari make diagnost product medic imag system surgic product
emphasi women health also make medic aesthet system
nm price-to-earnings oper ep
risk assess reflect particip
industri character rapid technolog chang new
industri standard new market entrant addit
compet number compani
significantli greater resourc product depth
includ ge siemen phillip fuji kodak toshiba
howev maintain healthi reput solid
market share breast imag gynecolog
nov ep estim base cfra oper earn
histor earn report compani report
cash dividend paid last year
past perform indic futur perform reli upon
analysi prepar equiti analyst
jul stock trade
target price recent
chang highlight
section stock report updat
invest rationale/risk section
stock report updat shortli
latest news stori marketscop
et cfra retain hold
rais target
below-p
ep estim
multipl near middl five-year
averag ratio jun-q ep vs
higher estim
rais fy sep ep
lower fy ep
currenc million driven growth
breast health intern busi
currenc intern busi grew
exclud acquir cynosur busi
announc departur cfo bob
mcmahon agil result chief
account offic karleen oberton
promot cfo also announc
acquisit faxitron leader digit
specimen radiographi million
expect continu make tuck-in
acquisit like near futur /kevin
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview develop manufactur supplier premium diagnost
product medic imag system surgic product emphasi women health
oper five segment diagnost revenu year end breast health
medic aesthet gyn surgic skelet health sell
servic product combin direct sale servic personnel network
independ distributor sale repres
offer wide rang diagnost product use primarili aid diagnosi human
diseas primari diagnost product includ holx aptima famili assay thinprep system
rapid fetal fibronectin test
breast health product includ broad portfolio breast imag relat product accessori
includ digit mammographi system computer-aid detect cad mammographi
minim invas breast biopsi devic breast biopsi site marker breast biopsi guidanc system
holx advanc breast imag platform dimens util technolog call tomosynthesi
produc imag show multipl contigu slice imag breast
medic aesthet segment offer portfolio aesthet treatment system sculpsur
enabl plastic surgeon dermatologist medic practition perform non-invas
minim invas procedur remov hair treat vascular benign pigment lesion remov
multi-color tattoo revit skin reduc fat laser lipolysi reduc cellulit clear nail
infect toe fungu ablat sweat gland improv gynecolog health
gyn surgic segment make product aim toward gynecolog health novasur
endometri ablat system skelet health segment offer product bone densitomet
imag system use assist perform minim invas surgic procedur
competit landscap holx wide array product face competit varieti
competitor includ competitor even broader product portfolio great brand recognit
current environ manag care economically-motiv buyer consolid among
healthcar provid increas competit declin reimburs rate
increasingli requir compet basi price valu reliabl effici
manufactur supplier broad array light-bas aesthet medic treatment system
product use provid divers rang treatment applic non-invas bodi
contour hair remov tattoo remov skin revit scar reduct well treatment
vascular lesion cynosur busi refer medic aesthet oper separ
januari divest blood screen busi grifol sale price
billion august acquir gen-prob lead maker molecular diagnost product
billion june acquir tct intern co ltd privat held distributor
medic product china acquisit tct provid establish nationwid sale
organ custom support infrastructur china
financi trend revenu grew billion sep billion five-year
cumul annual growth rate compound-annual-growth-rate adjust earn per share vs
five-year compound-annual-growth-rate adjust ep holx free cash flow defin cash
flow oper less capit expenditur neg million compar posit
million given net debt total capit ratio march recent weaker free
cash flow dont expect make larg acquisit near futur howev think
opportunist tuck-in acquisit like
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
bullish sinc june technic indic
bullish
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
stop medicaid expans senat
fail multipl time gather
suffici number vote pass variou
repeal replac bill howev republican
success elimin individu
mandat passag tcja
decemb see develop
neg health care equip
compani fewer insur patient
futur like lead fewer procedur
expect hospit largest
consum medic equip
advers impact could pressur
sale medic equip compani
includ increas global demand
qualiti health care age popul
rise outlay lead steadi flow
new diagnost therapeut product
 health equip
sub-index increas vs rise
 composit index year
date june health
increas composit index
fundament outlook health care
equip sub-industri next month
posit continu expect
compani sub-industri grow
addit sub-industri mani product
area histor
use non-elect procedur
constant currenc basi expect
revenu sub-industri rise
high-single-digit low-double-digit
percentag driven continu pipelin
expans acquisit speed
new product come market
increas recent year
success effort food drug
administr fda reduc approv
time medic devic time
see price pressur incess head wind
medic equip compani although
hospit saw boost cash tcja
tax cut job act think
hospit cautiou capit
budget amid on-going shift value-bas
care loom roll-off
medic devic tax sought rais
total billion year took
effect mani compani implement
cost optim measur respons
medic devic excis tax suspend
sinc begin
suspend till end compani
health care equip sub-industri stand
benefit medic devic tax repeal
develop
question opinion
recent republican administr
 difficulti attempt
repeal afford act
base index
five-year market price perform aug
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
analyst research note compani news
et cfra retain hold opinion share inc
rais target below-p
ep estim multipl near middl
five-year averag ratio jun-q ep vs
higher estim rais fy sep ep
lower fy ep jun-q sale increas
constant currenc million driven growth breast
health intern busi breast health sale grew
constant currenc intern busi grew exclud acquir
cynosur busi constant currenc august
announc departur cfo bob mcmahon agil result chief
account offic karleen oberton promot cfo also
announc acquisit faxitron leader digit specimen
radiographi million expect continu make tuck-in
acquisit like near futur /kevin huang cfa
lower target below-p
ep estim multipl close
holx five-year averag mar-q ep vs
lower estim sep ep estim remain
unchang sale increas million
howev due signific churn holx salesforc aggress
forecast cynosur growth prospect took million
impair charg mar-q relat recent acquir cynosur
busi revenu growth guidanc reduc
posit note intern revenu grew organ
constant currenc basi diagnost revenu exclud divest blood
screen busi declin breast health grew gyn surgic
declin holx capit alloc strategi expect
compani focu tuck-in acquisit supplement exist
rais target line peer
fy sep ep estim set fy
dec-q ep vs ahead estim sale rose
organ growth yet oper margin fell bp gross
margin declin bp due sale blood screen busi
cost rose inclus cynosur medic aesthet
acquisit lift fy sep ep guidanc
lower effect tax rate fy /jeffrey
keep target in-lin peer
forward ep estim jun-q ep vs
estim sale account sale blood screen
unit acquisit cynosur rose well growth
forecast howev gross margin fell product mix blood screen
higher margin oper margin declin bp due inclus
cynosur expens encourag sale growth anticip lower
inc lower fy sep fy ep
estim respect due sale
blood screen unit dec-q ep vs ahead
estim view sale blood screen unit posit saw
limit volatil sale growth sale rose diagnost
breast health gyn surgic skelet health fell
updat fy sale guidanc ep
account divestitur blood screen
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
